Will artificial intelligence empower us or overpower us?

A question of obsolescence

clock • 6 min read

In 2019, in an article for German publication 'Trends im Asset Management', an Invesco fund manager participated in a Q&A about the future of investment.

The very first question went to the heart of a shift that is reshaping this industry and many others: "How much time do you have left before the machines take over?" Although frivolous, the implication was undeniably relevant. The story of artificial intelligence (AI) and machine learning (ML) has long been defined by alternating bouts of optimism and dread, with the prospect of change encouraging eager expectation and the actual realisation of change prompting an alarm firmly rooted in fears of human obsolescence. The biggest artificial intelligence themes for the next decade Of c...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot